COMPARATIVE DRUG EXSORPTION IN THE PERFUSED RAT INTESTINE

被引:16
作者
HUANG, JD
机构
[1] Department of Pharmacology, National Cheng Kung University, Medical College, Tainan
关键词
D O I
10.1111/j.2042-7158.1990.tb05378.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Abstract— The factors affecting drug exsorption into the gastrointestinal tract are uncertain. In this study, the intestinal clearance (CLi) of compounds which vary in their lipophilicity, serum protein binding, molecular weight and ionic charge at physiological pH, has been measured. Male Sprague‐Dawley rats with ligated bile ducts were infused with the test compounds through the jugular vein. The small intestine was intubated and perfused with Tyrode solution at 20 mL h−1. The CLi of the compounds investigated (urea, polyethylene glycol, inulin, albumin, dextran, barbituric acid, salicylic acid, thiobarbital, thiopental, thioseconal, theophylline, S‐disopyramide and quinidine) was determined under anaesthesia by dividing the rate of a component's appearance rate in the perfusate by its carotid arterial concentration. Serum protein binding of the compounds was determined by equilibrium dialysis. The n‐octanol‐water partition coefficients of the compounds were measured as indices of lipophilicity. The CLi values of dextran, albumin, inulin, polyethylene glycol and urea were 0.56, 1.03, 4.5, 4.8 and 12.0 mL h−1, respectively. The larger the molecular weight of a compound, the smaller its CLi. The molecular weight is apparently one of the major determinants of CLi. Thiobarbital, thiopental and thioseconal are compounds of similar structure with increasing lipophilicity and serum protein binding. The CLi of thiobarbital, thiopental and thioseconal was proportional to the unbound fraction in serum. The unbound clearance (CLui) of three thiobarbiturates were similar (∼ 11 mL h−1). The unbound fraction of drug in serum appears to be a factor determining their CLi. Barbituric acid and salicylic acid, two acidic compounds, showed a low CLi (< 1 mL h−1). In contrast with barbituric acid and salicylic acid, the CLi of theophylline, S‐disopyramide and quinidine was much higher (> 30 mL h−1). The CLi of dextran, thiopental or S‐disopyramide was not affected by altered perfusion rate. Other than molecular weight and serum protein binding, the ionic charge of compounds at physiological pH was the most significant factor affecting CLi. The lipophilicity of compounds and the perfusion rate did not seem to be important factors. 1990 Royal Pharmaceutical Society of Great Britain
引用
收藏
页码:167 / 170
页数:4
相关论文
共 24 条
[1]   THE EFFECT OF ACTIVATED-CHARCOAL ON MOUSE SLEEP TIMES INDUCED BY INTRAVENOUSLY ADMINISTERED HYPNOTICS [J].
ADLER, LJ ;
WATERS, DH ;
GWILT, PR .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1986, 7 (05) :421-429
[2]   THE EFFECT OF CHARCOAL ON MEFENAMIC-ACID ELIMINATION [J].
ALLEN, EM ;
BUSS, DC ;
WILLIAMS, J ;
ROUTLEDGE, PA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (06) :830-832
[3]   DOSE-DEPENDENCY IN THE EXSORPTION OF THEOPHYLLINE AND THE INTESTINAL DIALYSIS OF THEOPHYLLINE BY ORAL ACTIVATED-CHARCOAL IN RATS [J].
ARIMORI, K ;
NAKANO, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (02) :101-105
[4]   ACCELERATED CLEARANCE OF INTRAVENOUSLY ADMINISTERED THEOPHYLLINE AND PHENOBARBITAL BY ORAL DOSES OF ACTIVATED-CHARCOAL IN RATS - A POSSIBILITY OF THE INTESTINAL DIALYSIS [J].
ARIMORI, K ;
NAKANO, M .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1986, 9 (05) :437-441
[5]  
ARIMORI K, 1985, J PHARMACOBIO-DYNAM, V8, P324
[6]   ACCELERATION OF THE BODY CLEARANCE OF PHENOBARBITAL BY ORAL ACTIVATED-CHARCOAL [J].
BERG, MJ ;
BERLINGER, WG ;
GOLDBERG, MJ ;
SPECTOR, R ;
JOHNSON, GF .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (11) :642-644
[7]   RESOLUTION, ABSOLUTE-CONFIGURATION, AND ANTI-ARRHYTHMIC PROPERTIES OF THE ENANTIOMERS OF DISOPYRAMIDE, 4-(DIISOPROPYLAMINO)-2-(2-PYRIDYL)-2-PHENYLBUTYRAMIDE [J].
BURKE, TR ;
NELSON, WL ;
MANGION, M ;
HITE, GJ ;
MOKLER, CM ;
RUENITZ, PC .
JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (09) :1044-1048
[8]   ELIMINATION OF DRUGS BY PASSIVE DIFFUSION FROM BLOOD TO INTESTINAL LUMEN - FACTORS INFLUENCING NONBILIARY EXCRETION BY THE INTESTINAL-TRACT [J].
DAYTON, PG ;
ISRAILI, ZH ;
HENDERSON, JD .
DRUG METABOLISM REVIEWS, 1983, 14 (06) :1193-1206
[9]   INTESTINAL SECRETION OF ERYTHROMYCIN BASE [J].
HOLLAND, DR ;
QUAY, JF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (03) :417-419